-Lipella Granted Two Orphan Drug Designations by FDA-
- Sales Grew 58% YOY; Backlog Grew 68% YOY and Remains Strong at $10.4 Million; Company Projects 30%...
Premier Press Release Services
Newswire Reimagined: Reach more investors, media and customers with precision targeting.